CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquired Accugenix, Inc. for ~$17M, a transaction completed in January 2012, structured as All-cash purchase.
Accugenix, Inc. operates in Manufacturing Solutions (Microbial Solutions), is based in United States (Newark, Delaware). Charles River acquired Accugenix, the premier global provider of cGMP-compliant contract microbial identification testing, based in Newark, Delaware. The acquisition strengthened Charles River's Endotoxin and Microbial Detection portfolio by adding DNA-sequencing-based microbial identification services for biopharmaceutical, medical device, nutraceutical and consumer-care manufacturing clients.
Strengthen Charles River's Endotoxin and Microbial Detection portfolio with cGMP-compliant contract microbial identification services for biopharmaceutical and other regulated manufacturing.
Advisory firms were not disclosed for this transaction.